Aglaia Oncology Funds
Karl Rothweiler has had extensive experience in the field of oncology funds and biotechnology investments. Karl has played key roles in various companies as a founding investor and member of the supervisory board. Karl has a strong background in business, holding degrees in Business Administration.
This person is not in any teams
Aglaia Oncology Funds
Aglaia is an investment fund fully focused on the fight against cancer and the development of improved anti-cancer drugs in particular. Aglaia has a proven ability to select and mature early-stage breakthrough inventions that have the potential to transform cancer treatment. For more information, please visit www.aglaia-oncology.com